Standard Family Office’s Moderna MRNA Stock Holding History

Standard Family Office’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-65	Closed	-$8K	–	285
2022 Q3	$8K	Hold	65	–	–	﹤0.01%	271
2022 Q2	$9K	Buy	+65	New	+$9.29K	0.09%	109
2022 Q1	–	Sell	-100	Closed	-$25K	–	178
2021 Q4	$25K	Buy	+100	New	+$29.2K	0.22%	83
2021 Q3	–	Sell	-13	Closed	-$3K	–	358
2021 Q2	$3K	Hold	13	–	–	﹤0.01%	312
2021 Q1	$2K	Hold	13	–	–	﹤0.01%	450
2020 Q4	$1K	Buy	+13	New	+$1.31K	﹤0.01%	549

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Standard Family Office's MRNA Position: Q4 2022 in Review

Standard Family Office sold out of Moderna (MRNA) in Q4 2022, closing a stake of 65 shares — an estimated $8K sold.

Standard Family Office first reported a position in MRNA in Q4 2020 and held it in 6 quarters. The position peaked at $25K in Q4 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

Standard Family Office reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
Standard Family Office sold 65 Moderna shares in Q4 2022, an estimated $8K.
Standard Family Office first reported a position in Moderna in Q4 2020 and held it in 6 quarters.
Standard Family Office's Moderna position peaked at $25K in Q4 2021.
1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.